About Luminex Corporate: Worldwide leader in Mulitplexed Solutions
Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's Luminex xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies.
» Further information on Luminex Corporation or xMAP can be obtained at www.luminexcorp.com.
Collaboration between Luminex Corporate and Wageningen UR
Wageningen UR and Luminex Corporation (NASDAQ: LMNX) have signed a licensing agreement to provide Wageningen UR access to Luminex's xMAP® technology and the Luminex Bioscience Group's assay development capabilities. Under the terms of the agreement, Wageningen UR will utilize Luminex's xMAP technology in selected areas of Agro Biotechnology. Focus application areas are expected to include plant pathogen detection, epidemiology, food safety, marker assisted plant and animal breeding. Prime Diagnostics will produce and supply the Luminex xMAP® based plant pathogenic detection kits.
» Press release: Wageningen UR and Luminex develop multiplex detection for the agricultural and food industries, April 2008
» Scientific publication: Multiplex microsphere immuno-detection of potato virus Y, X and PLRV, ScienceDirect March 2008